Search Results - M. Cleary
- Showing 1 - 20 results of 28
- Go to Next Page
-
1
Tulving’s (1989) Doctrine of Concordance Revisited by Bennett L. Schwartz, Anne M. Cleary
Published in Journal of Cognition (2025-05-01)Get full text
Article -
2
-
3
-
4
-
5
-
6
-
7
Detecting a familiar person behind the surgical mask: recognition without identification among masked versus sunglasses-covered faces by Brooke N. Carlaw, Andrew M. Huebert, Katherine L. McNeely-White, Matthew G. Rhodes, Anne M. Cleary
Published in Cognitive Research (2022-10-01)Get full text
Article -
8
-
9
Ten simple rules for developing visualization tools in genomics. by Eloi Durant, Mathieu Rouard, Eric W Ganko, Cedric Muller, Alan M Cleary, Andrew D Farmer, Matthieu Conte, Francois Sabot
Published in PLoS Computational Biology (2022-11-01)Get full text
Article -
10
-
11
Cabozantinib plus atezolizumab in previously untreated advanced hepatocellular carcinoma and previously treated gastric cancer and gastroesophageal junction adenocarcinoma: results... by Daneng Li, Yohann Loriot, Adam M. Burgoyne, James M. Cleary, Armando Santoro, Daniel Lin, Santiago Ponce Aix, Ignacio Garrido-Laguna, Ramu Sudhagoni, Xiang Guo, Svetlana Andrianova, Scott Paulson
Published in EClinicalMedicine (2024-01-01)Get full text
Article -
12
An Increase in Same-day Discharge After Total Joint Arthroplasty During the COVID-19 Pandemic Does Not Influence Patient Outcomes: A Retrospective Cohort Analysis by Brook A. Mitchell, BS, Liam M. Cleary, BS, Linsen T. Samuel, MD, MBA, Benjamin R. Coobs, MD, Miles A. Thomas, BS, Stephen C. Martinkovich, MD, Joseph T. Moskal, MD, FACS
Published in Arthroplasty Today (2023-04-01)Get full text
Article -
13
Secondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired resistance to ivosidenib in cholangiocarcinoma by James M. Cleary, Betty Rouaisnel, Antoine Daina, Srivatsan Raghavan, Lauren A. Roller, Brandon M. Huffman, Harshabad Singh, Patrick Y. Wen, Nabeel Bardeesy, Vincent Zoete, Brian M. Wolpin, Julie-Aurore Losman
Published in npj Precision Oncology (2022-09-01)Get full text
Article -
14
Kir4.1 channels contribute to astrocyte CO2/H+-sensitivity and the drive to breathe by Colin M. Cleary, Jack L. Browning, Moritz Armbruster, Cleyton R. Sobrinho, Monica L. Strain, Sarvin Jahanbani, Jaseph Soto-Perez, Virginia E. Hawkins, Chris G. Dulla, Michelle L. Olsen, Daniel K. Mulkey
Published in Communications Biology (2024-03-01)Get full text
Article -
15
Physical activity in older adults with metastatic gastrointestinal cancer: a pilot and feasibility study by Jeffrey A Meyerhardt, James M Cleary, Kimmie Ng, Brian M Wolpin, Nancy Campbell, Elizabeth Brighton, Nadine J McCleary, Peter C Enzinger, Justin C Brown, Thomas A Abrams, Douglas Rubinson, Matthew B Yurgelun
Published in BMJ Open Sport & Exercise Medicine (2022-05-01)Get full text
Article -
16
EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma. by Matthew E Randolph, Megan M Cleary, Zia Bajwa, Matthew N Svalina, Michael C Young, Atiya Mansoor, Pali Kaur, Carol J Bult, Martin W Goros, Joel E Michalek, Sunny Xiang, James Keck, Valery Krasnoperov, Parkash Gill, Charles Keller
Published in PLoS ONE (2017-01-01)Get full text
Article -
17
P328: DYNAMIC EVOLUTION OF TCF3-PBX1 LEUKEMIAS AT THE SINGLE-CELL LEVEL UNDER CHEMOTHERAPY PRESSURE by M. Kusterer, M. Lahnalampi, M. Voutilainen, G. Gentile, S. Pennisi, J. Norona, G. Greve, M. Lübbert, R. Sankowski, M. Prinz, S. Killmer, M. Salvat Lago, B. Bengsch, M. Cleary, V. Zachariadis, M. Enge, O. Lohi, M. Heinäniemi, J. Duque-Afonso
Published in HemaSphere (2022-06-01)Get full text
Article -
18
RETRACTED ARTICLE: Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer by Jeffrey Patterson-Fortin, Heta Jadhav, Constantia Pantelidou, Tin Phan, Carter Grochala, Anita K. Mehta, Jennifer L. Guerriero, Gerburg M. Wulf, Brian M. Wolpin, Ben Z. Stanger, Andrew J. Aguirre, James M. Cleary, Alan D. D’Andrea, Geoffrey I. Shapiro
Published in Nature Communications (2023-03-01)Get full text
Article -
19
Retraction Note: Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer by Jeffrey Patterson-Fortin, Heta Jadhav, Constantia Pantelidou, Tin Phan, Carter Grochala, Anita K. Mehta, Jennifer L. Guerriero, Gerburg M. Wulf, Brian M. Wolpin, Ben Z. Stanger, Andrew J. Aguirre, James M. Cleary, Alan D. D’Andrea, Geoffrey I. Shapiro
Published in Nature Communications (2023-12-01)Get full text
Article -
20
CITRINO: phase 1 dose escalation study of anti-LAG-3 antibody encelimab alone or in combination with anti-PD-1 dostarlimab in patients with advanced/metastatic solid tumours by J. Randolph Hecht, Jean-Marie Michot, David Bajor, Amita Patnaik, Ki Y. Chung, Judy Wang, Gerald Falchook, James M. Cleary, Richard Kim, Anuradha Krishnamurthy, Omkar Marathe, Hagop Youssoufian, Catherine Ellis, Angela Waszak, Srimoyee Ghosh, Hailei Zhang, Kaitlin Yablonski, Shruti D. Shah, Ivan Diaz-Padilla, Susanna Ulahannan
Published in BJC Reports (2025-02-01)Get full text
Article
